Speakers

Rafiq Hasan

Chief Executive Officer • Complement Therapeutics

Rafiq has pursued a highly successful career in the pharma industry globally, including senior positions in ophthalmology with Bayer and Novartis. Most recently as SVP and Global Head of Ophthalmology at Bayer, Rafiq grew the business of Eylea® from launch to over USD 2.5bn in 5 years, including its launch in 5 indications in 3 years.

Also speaking

Katrien Reynders

Board Member • Holland BIO

Tobias Brandt

Senior Scientist, Viral Vector Process Development • CSL Behring

Ohad Karnieli

Founder & Chief Executive Officer • Adva Biotechnology

Event Info

Image

Sample Attendee List – 2024

Download and explore the 2024 Floorplan for Advanced Therapies Europe here.
Image

Enquire to Sponsor/Exhibit

Take a look at the sample attendee list for Advanced Therapies Europe 2024 here.